A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Yong Ben.

Business address: C/O Bridgebio Oncology Therapeutics, Inc, 256 E. Grand Avenue, Suite 104, South San Francisco, CA, 94080
Top holdings (ownership): CRBP

Get insider transactions for this reporting owner

Yong Ben has filed 8 SEC EDGAR filings since 07 Mar 2023

Recent SEC filings for Yong Ben including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	28 Aug 2025	26 Aug 2025	001-41955
3	Open 3 document	View SEC filing for 3	3	18 Aug 2025	11 Aug 2025	001-41955
4	Open 4 document	View SEC filing for 4	4	02 Jun 2025	30 May 2025	001-37348
4	Open 4 document	View SEC filing for 4	4	03 Jun 2024	30 May 2024	001-37348
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	20 May 2024	16 May 2024	001-37348
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	22 May 2023	18 May 2023	001-37348
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	07 Mar 2023	06 Mar 2023	001-37348
3	Open 3 document	View SEC filing for 3	FORM 3 SUBMISSION	07 Mar 2023	06 Mar 2023	001-37348

Yong Ben files with the SEC under CIK 0001967669. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.